From: Giant fibroepithelial stromal polyp of the vulva: largest case reported
Aggressive angiomyxoma | Angiomyo-fibroblastoma | Cellular angiofibroma | Fibroepithelial stromal polyp | Superficial angiomyxoma | Prepubertal vulval fibroma | |
---|---|---|---|---|---|---|
Age | Reproductive age | Reproductive age | Reproductive age | Reproductive age | Reproductive age | Prepubertal |
Location/Configuration | Deep seated, not polypoid | Subcutaneous | Subcutaneous | Usually polypoid, exophytic | Superficial subcutaneous, polypoid | Submucosal, subcutaneous |
Size | Variable | Usually < 5 cm | Usually < 3 cm | Variable | Usually < 3 cm | Usually < 5 cm |
Margins | Infiltrative | Well circumscribed | Usually well circumscribed | Merges with normal | Lobulated, distinct | Infiltrative |
Cellularity | Paucicellular | Alternating hypercellular and hypocellular | Cellular | Variable | Hypocellular | Hypocellular |
Vessels | Medium to large, thick-walled, hyalinized | Delicate, capillary-sized, numerous | Small to medium, thick-walled, hyalinized | Variable, usually large, thick-walled central core | Delicate, thin-walled, elongated | Small to medium-sized vessels |
Mitotic Index | Rare | Usually uncommon | Variable, may be brisk | Variable | Usually uncommon | Uncommon |
Biomarkers | Desmin positive, HGMA2 positive | Desmin positive, HGMA2 negative | CD 34 positive; Desmin, SMA variable | Desmin positive, HGMA2 negative | Desmin negative, HGMA2 negative | CD 34 positive; desmin, S-100 negative |
Clinical course | 30% local destructive recurrence | Benign | Benign | Benign, rare recurrence | 30% local nondestructive recurrence | Benign, may recur |